10.2337/diabetes.36.4.523
10.1056/NEJM199306103282306
Garcia MJ, 1974, Diabetes, 23, 105, 10.2337/diab.23.2.105
10.1056/NEJM199309303291401
10.1016/0168-8227(95)01064-K
Meinert CL, 1970, Diabetes, 19, 789
1994, Diabetes Care, 17, 616, 10.2337/diacare.17.6.616
10.2337/diacare.17.10.1100
10.2337/diabetes.44.11.1249
10.2337/diabetes.37.12.1595
10.1056/NEJM199001253220403
10.2337/diabetes.38.5.550
10.1016/0026-0495(89)90064-4
10.2337/diabetes.40.2.166
10.1111/j.1464-5491.1988.tb00938.x
10.1016/0026-0495(90)90299-R
10.1056/NEJM198911023211805
Beckmann R. Biguanide (Experimenteller Teil). In: Maske H, ed. Oral wirksame Antidiabetika. Vol. 29 of Handbuch der experimentellen Pharmakologie. Berlin, Germany: Springer-Verlag, 1971:439-596.
Hermann LS, Melander A. Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. International textbook of diabetes mellitus. Vol. 1. Chichester, England: John Wiley, 1992:773-95.
10.1016/0306-3623(93)90411-P
10.2337/diabetes.36.5.632
Boyd K, 1992, Diabetes Res, 19, 69
10.1056/NEJM199508313330903
10.1016/0006-2952(88)90617-X
Bailey CJ, 1986, Diabetes Metab, 12, 212
10.1016/0026-0495(90)90259-F
Cigolini M, 1984, Diabetes Metab, 10, 311
10.2337/diabetes.40.7.850
10.1016/0026-0495(90)90171-8
10.2337/diabetes.42.8.1159
Riccio A, 1991, Diabetes Metab, 17, 180
10.2337/diabetes.43.7.920
10.1016/S0950-351X(88)80043-0
Bailey CJ, 1992, Br J Pharmacol, 105, 1009, 10.1111/j.1476-5381.1992.tb09093.x
Penicaud L, 1989, Biochem J, 262, 881, 10.1042/bj2620881
10.1111/j.1464-5491.1991.tb01610.x
10.1111/j.1464-5491.1992.tb01822.x
Somogyi A, 1987, Br J Clin Pharmacol, 23, 545, 10.1111/j.1365-2125.1987.tb03090.x
Hermann LS, 1990, Diabetes Care, 13, 37, 10.2337/diacare.13.3.37
10.1056/NEJM199508313330902
10.2165/00002018-199411040-00002
Lalau JD, 1989, Int J Clin Pharmacol Ther Toxicol, 27, 285
10.1001/archinte.152.11.2333